Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x)
Academic Article
Publication Date:
2022
abstract:
Following the publication of the original article [1], we were notified that the name of the 9th author was incorrectly spelled as Massimo FilippiBonassi, instead of Massimo Filippi. The original article has been corrected.
Iris type:
1.1.5. Erratum
List of contributors:
Barbanti, P.; Egeo, G.; Aurilia, C.; D'Onofrio, F.; Albanese, M.; Cetta, I.; Di Fiore, P.; Zucco, M.; Filippi, M.; Bono, F.; Altamura, C.; Proietti, S.; Bonassi, S.; Vernieri, F.
Published in: